Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.99 USD | +0.76% | +1.01% | -25.12% |
Apr. 17 | Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating | MT |
Apr. 15 | Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating | MT |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 1,636 | 944.8 | 941.6 | 729.1 | - | - |
Enterprise Value (EV) 1 | 1,294 | 725.4 | 676.1 | 481.2 | 440.9 | 335.7 |
P/E ratio | -10.6 x | -10.3 x | -15.9 x | -17.6 x | -26.4 x | - |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 8.46 x | 3.86 x | 3.53 x | 2.59 x | 2.36 x | 2.08 x |
EV / Revenue | 6.69 x | 2.96 x | 2.53 x | 1.71 x | 1.43 x | 0.96 x |
EV / EBITDA | -28.3 x | -14 x | 473 x | 30.6 x | 15.9 x | 8.83 x |
EV / FCF | -35.1 x | -14.6 x | 58.9 x | 20.8 x | 11.9 x | 6.16 x |
FCF Yield | -2.85% | -6.85% | 1.7% | 4.8% | 8.43% | 16.2% |
Price to Book | 5.76 x | 3.74 x | 3.73 x | 2.76 x | 2.73 x | 2.63 x |
Nbr of stocks (in thousands) | 83,348 | 84,506 | 88,247 | 91,936 | - | - |
Reference price 2 | 19.63 | 11.18 | 10.67 | 7.930 | 7.930 | 7.930 |
Announcement Date | 2/16/22 | 2/15/23 | 2/21/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | 193.3 | 245 | 267 | 280.9 | 308.7 | 349.9 |
EBITDA 1 | -45.68 | -51.86 | 1.428 | 15.75 | 27.73 | 38 |
EBIT 1 | -50.16 | -58.27 | -4.729 | 9.689 | 22.61 | 37.25 |
Operating Margin | -25.95% | -23.78% | -1.77% | 3.45% | 7.32% | 10.64% |
Earnings before Tax (EBT) 1 | -77.8 | -104.5 | -51.69 | -38.78 | - | - |
Net income 1 | -95.81 | -92.63 | -59.14 | -43.08 | - | - |
Net margin | -49.57% | -37.81% | -22.15% | -15.33% | - | - |
EPS 2 | -1.850 | -1.090 | -0.6700 | -0.4500 | -0.3000 | - |
Free Cash Flow 1 | -36.87 | -49.68 | 11.48 | 23.11 | 37.19 | 54.47 |
FCF margin | -19.07% | -20.28% | 4.3% | 8.23% | 12.04% | 15.57% |
FCF Conversion (EBITDA) | - | - | 804.27% | 146.74% | 134.11% | 143.34% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - |
Announcement Date | 2/16/22 | 2/15/23 | 2/21/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 50.59 | 53.26 | 56.85 | 59.94 | 63.35 | 64.86 | 65.89 | 66.16 | 67.02 | 67.89 | 68.11 | 69.26 | 70.89 | 72.86 | 73.98 |
EBITDA 1 | -8.934 | -17.6 | -17.27 | -15.34 | -9.913 | -9.34 | -7.457 | -0.928 | 3.281 | 6.396 | 2.442 | 3.533 | 4.768 | 5.359 | 5.2 |
EBIT 1 | -10.1 | -18.85 | -18.59 | -16.66 | -12.54 | -10.49 | -8.812 | -2.328 | 1.589 | 4.822 | 1.023 | 1.762 | 2.868 | 4.1 | 3.979 |
Operating Margin | -19.96% | -35.4% | -32.7% | -27.79% | -19.79% | -16.17% | -13.37% | -3.52% | 2.37% | 7.1% | 1.5% | 2.54% | 4.05% | 5.63% | 5.38% |
Earnings before Tax (EBT) 1 | -18.03 | -28.93 | -29.07 | -30.68 | -25.18 | -19.6 | -22.53 | -12.6 | -7.959 | -8.597 | -11.25 | -9.702 | -9.168 | -8.654 | - |
Net income 1 | -22.81 | -26.48 | -23.03 | -27.89 | -23.09 | -18.62 | -26.12 | -13.6 | -8.762 | -10.65 | -12.02 | -10.78 | -10.35 | -9.937 | - |
Net margin | -45.09% | -49.72% | -40.51% | -46.53% | -36.45% | -28.7% | -39.65% | -20.56% | -13.07% | -15.68% | -17.64% | -15.56% | -14.6% | -13.64% | - |
EPS 2 | -0.2700 | -0.3200 | -0.2700 | -0.3300 | -0.2700 | -0.2200 | -0.3000 | -0.1500 | -0.1000 | -0.1200 | -0.1250 | -0.1200 | -0.1050 | -0.1050 | -0.0800 |
Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/10/21 | 2/16/22 | 5/23/22 | 8/11/22 | 11/15/22 | 2/15/23 | 5/17/23 | 8/10/23 | 11/14/23 | 2/21/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 342 | 219 | 266 | 248 | 288 | 393 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -36.9 | -49.7 | 11.5 | 23.1 | 37.2 | 54.5 |
ROE (net income / shareholders' equity) | -36.1% | -34.3% | 1.43% | 4.41% | 6.43% | 8.77% |
ROA (Net income/ Total Assets) | -16% | -20.5% | 0.82% | - | - | - |
Assets 1 | 599.1 | 452.4 | -7,255 | - | - | - |
Book Value Per Share 2 | 3.410 | 2.990 | 2.860 | 2.870 | 2.900 | 3.020 |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | 2.64 | 2.87 | 0.54 | 1 | 2.93 | 0.6 |
Capex / Sales | 1.37% | 1.17% | 0.2% | 0.36% | 0.95% | 0.17% |
Announcement Date | 2/16/22 | 2/15/23 | 2/21/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.12% | 729M | |
-19.32% | 26.53B | |
+1.69% | 9.32B | |
-6.43% | 4.6B | |
-1.92% | 479M | |
-9.63% | 273M | |
-28.88% | 210M | |
-42.63% | 189M | |
-4.81% | 152M | |
-38.99% | 149M |
- Stock Market
- Equities
- WKME Stock
- Financials WalkMe Ltd.